Leukosite develops drugs to block disease promoting actions of white blood cells, with potential applications within the areas of cancer, autoimmune and viral diseases.
215 First Street
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Gaithersburg, Maryland, United States||IPO / Went public||GlycoMimetics is developing small molecule drugs that mimic the actions of carbohydrates using glycobiology. The company is focusing its initial efforts on therapeutics to treat inflammatory diseases such as cystic fibrosis and cancer.||Login to see details|
|Cambridge, Massachusetts, United States||Dead / Inactive||Peptimmune develops drugs for the treatment of various autoimmune diseases.||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)